Targeted screening for diabetes in community chiropody clinics.
Population screening for diabetes mellitus is of uncertain value. We therefore assessed the value of screening amongst community chiropody clinic attenders in Liverpool. All attenders aged between 40 and 75 years during a 3-month period were offered screening by urine glucose self-testing, 2 hours post-prandially, backed up with glucose tolerance tests (GTT) for positive respondents. Of 1058 patients screened, 11 (1.0%) reported positive results, of whom four (0.4% of total) had diabetes, and two had impaired glucose tolerance (IGT). Screening costs were 11p per person, 2.06 pounds per 'positive' person, and 34.46 pounds for each newly diagnosed patient. The screening procedure was simple and highly cost-effective, but the diagnostic returns were only moderate. This may have been because of a high rate of known diabetes amongst the chiropody clinic attenders (17.3%). In view of this, routine widespread diabetes screening in chiropody clinics cannot at present be recommended.
Gill
G V
GV
Diabetes Centre, Walton Hospital, Liverpool, UK.
Lishman
M
M
Kaczmarczyk
E
E
Tesfaye
S
S
D000328:Adult; D000368:Aged; D003153:Community Health Services; D003365:Costs and Cost Analysis; D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis*; D005951:Glucose Tolerance Test; D006801:Humans; D008403:Mass Screening / Q000191:economics; D008875:Middle Aged; D011032:Podiatry; D012307:Risk Factors